These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 8805786)
1. The potential of antioxidants to prevent atherosclerosis development and its clinical manifestations. Pettersson KS; Ostlund-Lindqvist AM; Westerlund C EXS; 1996; 76():21-31. PubMed ID: 8805786 [No Abstract] [Full Text] [Related]
2. The resistance of low density lipoprotein to oxidation promoted by copper and its use as an index of antioxidant therapy. O'Leary VJ; Tilling L; Fleetwood G; Stone D; Darley-Usmar V Atherosclerosis; 1996 Jan; 119(2):169-79. PubMed ID: 8808494 [TBL] [Abstract][Full Text] [Related]
3. [Antioxidant probucol is an efficient trap for lipid radicals in LDL in vitro and in vivo]. Tikhaze AK; Lankin VZ; Konovalova GG; Shumaev KB; Kaminnyĭ AI; Kozachenko AI; Gurevich SM; Nagler LG; Zaĭtseva TM; Kukharchuk VV Biull Eksp Biol Med; 1999 Aug; 127(8):186-9. PubMed ID: 11188741 [No Abstract] [Full Text] [Related]
4. Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice. Bird DA; Tangirala RK; Fruebis J; Steinberg D; Witztum JL; Palinski W J Lipid Res; 1998 May; 39(5):1079-90. PubMed ID: 9610776 [TBL] [Abstract][Full Text] [Related]
5. Vitamin E and atherosclerosis: an overview. Esterbauer H; Puhl H; Waeg G; Krebs A; Tatzber F; Rabl H J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():177-82. PubMed ID: 1297735 [No Abstract] [Full Text] [Related]
6. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis. Lee HS; Jeong JY; Kim BC; Kim YS; Zhang YZ; Chung HK Kidney Int; 1997 Apr; 51(4):1151-9. PubMed ID: 9083281 [TBL] [Abstract][Full Text] [Related]
7. Effect of lipid peroxidation products and antioxidants on the formation of probucol radical in low density lipoproteins. Shumaev KB; Ruuge EK; Dmitrovsky AA; Bykhovsky VYa ; Kukharchuk VV Biochemistry (Mosc); 1997 Jun; 62(6):657-60. PubMed ID: 9284547 [TBL] [Abstract][Full Text] [Related]
8. Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza. Wu YJ; Hong CY; Lin SJ; Wu P; Shiao MS Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):481-6. PubMed ID: 9514418 [TBL] [Abstract][Full Text] [Related]
9. The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters. El-Swefy S; Schaefer EJ; Seman LJ; van Dongen D; Sevanian A; Smith DE; Ordovas JM; El-Sweidy M; Meydani M Atherosclerosis; 2000 Apr; 149(2):277-86. PubMed ID: 10729377 [TBL] [Abstract][Full Text] [Related]
10. [Mechanisms of anti-atherogenic action of probucol]. Ohya T; Egusa G Nihon Rinsho; 1999 Dec; 57(12):2831-6. PubMed ID: 10638221 [TBL] [Abstract][Full Text] [Related]
11. Thyronines and probucol inhibition of human capillary endothelial cell-induced low density lipoprotein oxidation. Hanna AN; Titterington LC; Lantry LE; Stephens RE; Newman HA Biochem Pharmacol; 1995 Nov; 50(10):1627-33. PubMed ID: 7503765 [TBL] [Abstract][Full Text] [Related]
12. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. Keaney JF; Xu A; Cunningham D; Jackson T; Frei B; Vita JA J Clin Invest; 1995 Jun; 95(6):2520-9. PubMed ID: 7769097 [TBL] [Abstract][Full Text] [Related]
14. Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. III. The protective effect of antioxidants (probucol, catechin, vitamin E) against the cytotoxicity of oxidized LDL occurs in two different ways. Negre-Salvayre A; Alomar Y; Troly M; Salvayre R Biochim Biophys Acta; 1991 Jun; 1096(4):291-300. PubMed ID: 2065102 [TBL] [Abstract][Full Text] [Related]
15. Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action. Keaney JF; Vita JA Prog Cardiovasc Dis; 1995; 38(2):129-54. PubMed ID: 7568903 [TBL] [Abstract][Full Text] [Related]